Live Breaking News & Updates on Fcpix

Stay updated with breaking news from Fcpix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

StockNews.com Begins Coverage on Cumberland Pharmaceuticals (NASDAQ:CPIX)

Research analysts at StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Get Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock. Cumberland Pharmaceuticals Price Performance Shares of CPIX stock opened at $1.42 on Thursday. Cumberland Pharmaceuticals has […] ....

United States , Institutional Investors Weigh In On Cumberland Pharmaceuticals , York Mellon Corp , News Ratings For Cumberland Pharmaceuticals Daily , Cumberland Pharmaceuticals Inc , Cumberland Pharmaceuticals Price Performance , Cumberland Pharmaceuticals Company Profile , Cumberland Pharmaceuticals , Get Free Report , New York Mellon Corp , Free Report , Pharmaceuticals Inc , Cumberland Pharmaceuticals Daily , Nasdaq Cpix , Initiated Coverage , Stocknews Com ,

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Short Interest Update

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX – Get Free Report) saw a significant drop in short interest in December. As of December 15th, there was short interest totalling 18,100 shares, a drop of 10.0% from the November 30th total of 20,100 shares. Based on an average daily trading volume, of 14,100 shares, the days-to-cover ratio is currently […] ....

United States , Cumberland Pharmaceuticals Company Profile , Renaissance Technologies , Cumberland Pharmaceuticals Price Performance , York Mellon Corp , News Ratings For Cumberland Pharmaceuticals Daily , Cumberland Pharmaceuticals , Cumberland Pharmaceuticals Inc , Millennium Management , Hedge Funds Weigh In On Cumberland Pharmaceuticals , B Riley Wealth Advisors Inc , Acadian Asset Management , Get Free Report , Asset Management , Wealth Advisors , New York Mellon Corp , Pharmaceuticals Inc , Cumberland Pharmaceuticals Daily , Nasdaq Cpix ,

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Short Interest Down 10.0% in December

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX – Get Free Report) was the recipient of a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 18,100 shares, a drop of 10.0% from the November 30th total of 20,100 shares. Currently, 0.2% of the company’s shares are sold short. […] ....

United States , Renaissance Technologies , Cumberland Pharmaceuticals Company Profile , B Riley Wealth Advisors Inc , News Ratings For Cumberland Pharmaceuticals Daily , Cumberland Pharmaceuticals Inc , Cumberland Pharmaceuticals Trading Down , Millennium Management , Acadian Asset Management , Cumberland Pharmaceuticals , York Mellon Corp , Get Free Report , New York Mellon Corp , Wealth Advisors , Asset Management , Pharmaceuticals Trading Down , Pharmaceuticals Inc , Cumberland Pharmaceuticals Daily , Nasdaq Cpix ,

Cumberland Pharmaceuticals (NASDAQ:CPIX) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research note issued to investors on Monday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Cumberland Pharmaceuticals Trading Up 1.2 % NASDAQ:CPIX opened at $1.74 on Monday. The company has a market capitalization of $25.93 million, a […] ....

United States , York Mellon Corp , Renaissance Technologies , B Riley Wealth Advisors Inc , Hedge Funds Weigh In On Cumberland Pharmaceuticals , Cumberland Pharmaceuticals Trading , Cumberland Pharmaceuticals Inc , Acadian Asset Management , Cumberland Pharmaceuticals Company Profile , Millennium Management , News Ratings For Cumberland Pharmaceuticals Daily , Cumberland Pharmaceuticals , Free Report , Get Free Report , New York Mellon Corp , Wealth Advisors , Asset Management , Pharmaceuticals Inc , Cumberland Pharmaceuticals Daily , Nasdaq Cpix , Initiated Coverage , Stocknews Com ,

Cumberland Pharmaceuticals (NASDAQ:CPIX) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research note issued to investors on Sunday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Cumberland Pharmaceuticals Stock Performance Shares of NASDAQ:CPIX opened at $1.78 on Friday. The business’s fifty day moving average price is $1.85 and […] ....

United States , Renaissance Technologies , Cumberland Pharmaceuticals Inc , Cumberland Pharmaceuticals , News Ratings For Cumberland Pharmaceuticals Daily , York Mellon Corp , Hedge Funds Weigh In On Cumberland Pharmaceuticals , Cumberland Pharmaceuticals Company Profile , Acadian Asset Management , B Riley Wealth Advisors Inc , Millennium Management , Cumberland Pharmaceuticals Stock Performance , Free Report , Get Free Report , New York Mellon Corp , Wealth Advisors , Asset Management , Pharmaceuticals Inc , Cumberland Pharmaceuticals Daily , Nasdaq Cpix , Initiated Coverage , Stocknews Com ,